SCHEMBL26307337

SCHEMBL26307337

CCOC(=O)CCc1ccc(CO)cc1CC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 4/20 0.63
CYP4A11 Q02928 4/20 0.63
CYP4Z1 Q86W10 2/20 0.44
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43
CYP4F11 Q9HBI6 1/20 0.42
CYP4F12 Q9HCS2 1/20 0.42
ALOX5 P09917 1/20 0.40
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
P2RY12 Q9H244 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
FAAH O00519 1/20 0.40
CA12 O43570 1/20 0.39
CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25629661 0.87 CYP4F2 (0.54) CYP4F2CYP4A11CYP4Z1ALDH1A1GAA
SCHEMBL3499415 0.85 CYP4F2 (0.56) CYP4F2CYP4A11CYP4Z1ALDH1A1GAA
SCHEMBL146903 0.84 CYP4F2 (0.55) CYP4F2CYP4A11CYP4Z1ALDH1A1GAA
SCHEMBL30434824 0.84 CYP4F2 (0.55) CYP4F2CYP4A11CYP4Z1ALDH1A1GAA
SCHEMBL4521152 0.81 CYP4F2 (0.58) CYP4F2CYP4A11ALDH1A1GAACA12
SCHEMBL4889211 0.80 CYP4F2 (0.80) CYP4F2CYP4A11CYP4Z1CYP4F11CYP4F12
SCHEMBL5990173 0.80 CYP4F2 (0.56) CYP4F2CYP4A11CYP4Z1ALDH1A1GAA
SCHEMBL25629660 0.80 CYP4F2 (0.56) CYP4F2CYP4A11ALDH1A1GAACYP1A2
SCHEMBL20289308 0.80 CYP4F2 (0.64) CYP4F2CYP4A11CYP4Z1ALDH1A1GAA
SCHEMBL26307358 0.79 CYP4F2 (0.55) CYP4F2CYP4A11CYP4Z1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227412-A1 Substituted Benzimidazole Derivative And Use Thereof CHENGDU FANXI BIOPHARMA CO., LTD. (CN) 2023-07-20 US disclosed
US-20230227412-A1 Substituted Benzimidazole Derivative And Use Thereof CHENGDU FANXI BIOPHARMA CO., LTD. (CN) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227412-A1 Substituted Benzimidazole Derivative And Use Thereof PPARD, PPARG, PPARA CYP4F2 1840/4885CYP4A11 505/4885CYP4Z1 2267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.